⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL821227 | 0.80 | — | — | |
| SCHEMBL11102459 | 0.78 | — | — | |
| SCHEMBL11104026 | 0.78 | — | — | |
| SCHEMBL3499897 | 0.75 | — | — | |
| SCHEMBL17704772 | 0.70 | — | — | |
| SCHEMBL11097010 | 0.70 | KMT2A (0.36) | — | |
| SCHEMBL11102000 | 0.69 | MIF (0.33) | — | |
| SCHEMBL3193395 | 0.69 | — | — | |
| SCHEMBL11097087 | 0.69 | CRBN (0.34) | — | |
| SCHEMBL11100095 | 0.69 | MAPT (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9334299-B2 | Water-soluble camptothecin derivative, pharmaceutical composition and use thereof | HUNAN FANGSHENGHUAMEI MEDICAL TECH. CO. LTD. (CN) | 2016-05-10 | — | — | US | claimed |
| CN-102153607-B | Water soluble camptothecin derivative and medicinal composition containing same | HUNAN FANGSHENG HUAMEI MEDICAL TECHNOLOGY CO LTD | 2015-07-15 | — | — | CN | claimed |
| US-20140155336-A1 | WATER-SOLUBLE CAMPTOTHECIN DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF | HUNAN FANGSHENGHUAMEI MEDICAL TECH. CO. LTD. (CN) | 2014-06-05 | — | — | US | claimed |
| CN-102153607-A | Water soluble camptothecin derivative and medicinal composition containing same | HUNAN FANGSHENG HUAMEI MEDICAL TECHNOLOGY CO LTD | 2011-08-17 | — | — | CN | claimed |
| US-20250313838-A1 | NUCLEIC ACID FOR TRANSFECTION | AGC Inc. (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4585684-A1 | NUCLEIC ACID FOR TRANSFECTION | AGC INC. (JP) | 2025-07-16 | — | — | EP | disclosed |
| CN-119731318-A | Nucleic acid for transfection | ＡＧＣ株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-119654411-A | Method for producing oligonucleotide | 味之素株式会社 | 2025-03-18 | — | — | CN | disclosed |
| CN-119487210-A | Repeated short read sequencing within a cell sample | 元素生物科学公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20240009224-A1 | ACYCLIC THREONINOL NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-4303303-A1 | ACYCLIC THREONINOL NUCLEIC ACID | The University of Tokyo (JP) | 2024-01-10 | — | — | EP | disclosed |
| CN-116917476-A | Acyclic threitol nucleic acids | 国立大学法人东京大学 | 2023-10-20 | — | — | CN | disclosed |
| US-5384251-A | Culture of Bacillus to produce nucleoside phosphorylase | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1995-01-24 | — | — | US | disclosed |
| US-5258301-A | Nucleoside phosphorylase from Bacillus | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1993-11-02 | — | — | US | disclosed |
| EP-0411158-A1 | Process for producing nucleosides by using phosphorylases obtainable from Bacillus stearothermophilus | Yamasa Shoyu Kabushiki Kaisha (Yamasa Corporation) (JP) | 1991-02-06 | — | — | EP | disclosed |
| EP-0233493-A2 | Process for producing ribonucleosides | Yamasa Shoyu Kabushiki Kaisha (JP) | 1987-08-26 | — | — | EP | disclosed |
| US-4477442-A | PENTOFURANOSYL-5,6-DIHYDROTRIAZINES IN TREATMENT OF VIRAL DISEASES | THE UPJOHN COMPANY (US) | 1984-10-16 | — | — | US | disclosed |
| US-4423212-A | Nucleosides and process | THE UPJOHN COMPANY (US) | 1983-12-27 | — | — | US | disclosed |
| US-4239753-A | Composition of matter and process | THE UPJOHN COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4171431-A | Nucleosides and process | THE UPJOHN COMPANY (US) | 1979-10-16 | — | — | US | disclosed |